Key facts
- It has raised $2.5M; the latest was Early Stage VC ($2.5M) in Oct 2025.
- Notable investors include Antler, Redesign Health, Sanabil Venture Studio.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Nuxera
- ·The full record, as it builds
Funding rounds
No funding rounds for Nuxera are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nuxera
Developer of an artificial intelligence-powered healthcare platform designed to streamline medical documentation and clinic management. The company offers real-time voice transcription, automated documentation, multi-language support, and EMR integration, enabling healthcare professionals to reduce administrative workload and focus more on patient care.
- Sector
- Information Technology
- HQ
- Riyadh, Saudi Arabia
- Founded
- 2024
- Website
- nuxera.ai/
- Ownership
- Privately Held (backing)
Nuxera doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nuxera shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nuxera in its N-PORT filings yet. We sweep new filings monthly.